Literature DB >> 16839428

The nomenclature, definition and classification of hypoplastic left heart syndrome.

Christo I Tchervenkov1, Jeffrey P Jacobs, Paul M Weinberg, Vera D Aiello, Marie J Béland, Steven D Colan, Martin J Elliott, Rodney C G Franklin, J William Gaynor, Otto N Krogmann, Hiromi Kurosawa, Bohdan Maruszewski, Giovanni Stellin.   

Abstract

The hypoplastic left heart syndrome encompasses a spectrum of cardiac malformations that are characterized by significant underdevelopment of the components of the left heart and the aorta, including the left ventricular cavity and mass. At the severe end of the spectrum is found the combination of aortic and mitral atresia, when the left ventricle can be close to non-existent. At the mild end are the patients with hypoplasia of the aortic and mitral valves, but without intrinsic valvar stenosis or atresia, and milder degrees of left ventricular hypoplasia. Although the majority of the patients are suitable only for functionally univentricular repair, a small minority may be candidates for biventricular repair. The nature of the syndrome was a topic for discussion at the second meeting of the International Working Group for Mapping and Coding of Nomenclatures for Paediatric and Congenital Heart Disease, the Nomenclature Working Group, held in Montreal, Canada, over the period January 17 through 19, 2003. Subsequent to these discussions, the Nomenclature Working Group was able to create a bidirectional crossmap between the nomenclature initially produced jointly on behalf of the European Association for Cardio-Thoracic Surgery and the Society of Thoracic Surgeons, and the alternative nomenclature developed on behalf of the Association for European Paediatric Cardiology. This process is a part of the overall efforts of the Nomenclature Working Group to create a comprehensive and all-inclusive international system of nomenclature for paediatric and congenital cardiac disease, the International Paediatric and Congenital Cardiac Code. In this review, we discuss the evolution of nomenclature and surgical treatment for the spectrum of lesions making up the hypoplastic left heart syndrome and its related malformations. We also present the crossmap of the associated terms for diagnoses and procedures, as recently completed by the Nomenclature Working Group.

Entities:  

Mesh:

Year:  2006        PMID: 16839428     DOI: 10.1017/S1047951106000291

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  31 in total

1.  Complications after the Norwood operation: an analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  Christoph P Hornik; Xia He; Jeffrey P Jacobs; Jennifer S Li; Robert D B Jaquiss; Marshall L Jacobs; Sean M O'Brien; Eric D Peterson; Sara K Pasquali
Journal:  Ann Thorac Surg       Date:  2011-09-19       Impact factor: 4.330

2.  Anatomical Details Should Accompany Studies of Hypoplastic Left Heart Syndrome.

Authors:  E Vittery; J O'Sullivan; S Polyviou; L Coats; B Chaudhry
Journal:  Pediatr Cardiol       Date:  2019-05-14       Impact factor: 1.655

3.  Congenital coronary arteriopathy and myocardial infarctions occur with tricuspid atresia.

Authors:  Brett R Anderson; Diane Rhee; Rosanna G Abellar; Julie S Glickstein
Journal:  Pediatr Cardiol       Date:  2012-05-24       Impact factor: 1.655

4.  Congenital heart disease linked to maternal autoimmunity against cardiac myosin.

Authors:  Charles R Cole; Katherine E Yutzey; Anoop K Brar; Lisa S Goessling; Sarah J Van Vickle-Chavez; Madeleine W Cunningham; Pirooz Eghtesady
Journal:  J Immunol       Date:  2014-03-26       Impact factor: 5.422

Review 5.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

6.  PCB126 exposure disrupts zebrafish ventricular and branchial but not early neural crest development.

Authors:  Adrian C Grimes; Kyle N Erwin; Harriett A Stadt; Ginger L Hunter; Holly A Gefroh; Huai-Jen Tsai; Margaret L Kirby
Journal:  Toxicol Sci       Date:  2008-07-26       Impact factor: 4.849

Review 7.  Nomenclature and databases - the past, the present, and the future : a primer for the congenital heart surgeon.

Authors:  Jeffrey Phillip Jacobs; Constantine Mavroudis; Marshall Lewis Jacobs; Bohdan Maruszewski; Christo I Tchervenkov; Francois G Lacour-Gayet; David Robinson Clarke; J William Gaynor; Thomas L Spray; Hiromi Kurosawa; Giovanni Stellin; Tjark Ebels; Emile A Bacha; Henry L Walters; Martin J Elliott
Journal:  Pediatr Cardiol       Date:  2007-05-04       Impact factor: 1.655

8.  Severe left ventricular hypoplasia in patients with unbalanced incomplete atrioventricular septal defect and pulmonary hypertension: feasibility of biventricular repair.

Authors:  Christian Apitz; Renate Kaulitz; Gerhard Ziemer; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2008-07-02       Impact factor: 1.655

9.  Postnatal course of hypoplastic left heart complex and restrictive foramen ovale.

Authors:  Koa Hosoki; Yoshihide Mitani; Shin Takabayashi; Hideto Shimpo; Yoshihiro Komada
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

10.  The importance of nomenclature for congenital cardiac disease: implications for research and evaluation.

Authors:  Matthew J Strickland; Tiffany J Riehle-Colarusso; Jeffrey P Jacobs; Mark D Reller; William T Mahle; Lorenzo D Botto; Paige E Tolbert; Marshall L Jacobs; Francois G Lacour-Gayet; Christo I Tchervenkov; Constantine Mavroudis; Adolfo Correa
Journal:  Cardiol Young       Date:  2008-12       Impact factor: 1.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.